使用功能化辅助单元结合物进行表观遗传药物的有效非侵入性输送.
1Tashima Laboratories of Arts and Sciences, 1239-5 Toriyama-cho, Kohoku-ku, Yokohama 222-0035, Kanagawa, Japan.
Pharmaceutics
|January 28, 2026
概括
表观遗传药物向基因表达变化而不改变DNA. 功能化的辅助单元改善了这些疗法的交付,克服了诸如透性差等挑战,以更好地治疗疾病.
科学领域:
- 制药科学 制药科学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 表观遗传学涉及遗传性基因表达变化 (DNA甲基化,基因质修饰,非编码RNA) 没有DNA序列改变.
- 针对表观遗传机制为疾病提供了根源干预,推动了制药科学的进步.
- 已批准的表观遗传药物存在,但面临的交付挑战,如薄膜透性和生物分布.
研究的目的:
- 审查表观遗传药物的非侵入性输送的潜力和优势.
- 讨论在表观遗传调节器中使用功能化辅助单元克服传递障碍.
主要方法:
- 这篇叙事综述综合了关于表观遗传药物递送的当前研究.
- 专注于将功能化的辅助单元纳入表观遗传调节器的策略.
主要成果:
- 功能化的辅助单元,作为载体或载体,可以增强表观遗传药物递送.
- 辅助单元的例子包括细胞透,瘤定位和纳米粒子.
- 这些合物显示出克服常见药物输送障碍的潜力.
结论:
- 功能化的辅助单元合物为表观遗传药物有效的非侵入性输送提供了一个有希望的策略.
- 这种方法可以通过解决目前表观遗传药物开发的局限性来改善治疗结果.
关键词:
抗体药物合物 抗体药物合物癌症治疗疗法 癌症治疗运营商介于运输的运输方式是运营商.传递药物的表观遗传药物传递.表观遗传学是指表观遗传学.通过纳米粒子介导的交付.受体介导的内细胞结合症受体介导的内细胞结合症更多相关视频
相关概念视频
Conjugated Proteins
28.6K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
28.6K
Epigenetic Regulation
33.7K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.7K
Accessory Organs
74.2K
Accessory organs are those that participate in the digestion of food but do not come into direct contact with it like the mouth, stomach, or intestine do. Accessory organs secrete enzymes into the digestive tract to facilitate the breakdown of food.
74.2K
Drug Delivery: Overview
827
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
827
Buffer Effectiveness
55.1K
Buffer solutions do not have an unlimited capacity to keep the pH relatively constant . Instead, the ability of a buffer solution to resist changes in pH relies on the presence of appreciable amounts of its conjugate weak acid-base pair. When enough strong acid or base is added to substantially lower the concentration of either member of the buffer pair, the buffering action within the solution is compromised.
The buffer capacity is the amount of acid or base that can be added to a given volume...
The buffer capacity is the amount of acid or base that can be added to a given volume...
55.1K
Drug Delivery: Enteral Route
1.7K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.7K


